First Time Loading...

Incyte Corp
NASDAQ:INCY

Watchlist Manager
Incyte Corp Logo
Incyte Corp
NASDAQ:INCY
Watchlist
Price: 57.79 USD 0.86% Market Closed
Updated: Jun 1, 2024

Incyte Corp
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Incyte Corp
Other Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Incyte Corp
NASDAQ:INCY
Other Current Assets
$189.2m
CAGR 3-Years
37%
CAGR 5-Years
21%
CAGR 10-Years
29%
Abbvie Inc
NYSE:ABBV
Other Current Assets
$4.6B
CAGR 3-Years
5%
CAGR 5-Years
21%
CAGR 10-Years
6%
Gilead Sciences Inc
NASDAQ:GILD
Other Current Assets
$2.8B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Other Current Assets
$2.8B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Assets
$511.1m
CAGR 3-Years
15%
CAGR 5-Years
31%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Assets
$414.9m
CAGR 3-Years
25%
CAGR 5-Years
18%
CAGR 10-Years
17%

See Also

What is Incyte Corp's Other Current Assets?
Other Current Assets
189.2m USD

Based on the financial report for Mar 31, 2024, Incyte Corp's Other Current Assets amounts to 189.2m USD.

What is Incyte Corp's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
29%

Over the last year, the Other Current Assets growth was -3%. The average annual Other Current Assets growth rates for Incyte Corp have been 37% over the past three years , 21% over the past five years , and 29% over the past ten years .